InvestSMART

Clarity Pharmaceuticals Ltd (ASX:CU6)

ALERT: Price-sensitive ASX Announcement for CU6
Current share price for CU6 : $2.320 -0.85 (-26.81%)+
Announcement
Release
5 Sep 2025 5:08PM
Price at Release
$3.170
Full Release
download
Summary
The S&P Dow Jones Indices announced changes in several Australian indices as part of their September 2025 quarterly rebalance, effective prior to trading on September 22, 2025. In this rebalance, Clarity Pharmaceuticals Limited (CU6) was removed from the S&P/ASX 200 Index, reflecting a shift in index composition designed to maintain market efficiency and representation. Several companies were either added to or removed from indices such as the S&P/ASX 50, S&P/ASX 100, and S&P/ASX 300, as well as the All Ordinaries and S&P/ASX All Technology Index, with the goal of adjusting to current market conditions and maintaining alignment with the indices’ strategic objectives.
Key Points
  • S&P Dow Jones Indices announces September 2025 quarterly rebalance.
  • Clarity Pharmaceuticals Limited (CU6) removed from S&P/ASX 200 Index.
  • Changes effective prior to trading on September 22, 2025.
  • Rebalance includes additions and removals across multiple indices.
  • Adjustments aim to maintain market efficiency and representation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.